ArticlePolish journal of radiology2025
Endovascular embolization of dural arteriovenous fistulas: an 8-year single-centre experience and comparison with contemporary literature.
Article in Polish journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Dural arteriovenous fistulas (DAVFs) are complex vascular malformations characterised by abnormal communications between the meningeal arteries and dural venous sinuses or cortical veins. They may be associated with underlying thrombotic associations such as the presence of cerebral venous sinus thrombosis (CVST) or transverse-sigmoid sinus (TSS) occlusion, which can affect prognostic outcomes. Additionally, the types of DAVFs may also have varying clinical and technical outcomes. Material and methods: This study was a retrospective cohort analysis conducted on 27 DAVF patients from 2015 to 2023 who presented at Aga Khan University Hospital, Karachi. We examined the fistula types, clinical and technical success rates, complications, recurrence and the presence of concurrent CVST or TSS. Results: Complete clinical and technical success rates were 44% and 63%, respectively. The rates of complications and recurrence were 18.5% and 19%, respectively. The presence of thrombotic associations (CVST and TSS occlusion) was associated with significantly lower clinical success rates in our cohort. Type II Cognard fistulas were significantly associated with the presence of CVST and TSS occlusion ( Conclusions: Our findings advocate for comprehensive recognition of thrombotic associations of DAVFs and their potential integration into classification systems to better determine prognostic outcomes. Large-scale multi-centre studies are required to validate these associations further and guide treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.